Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
5R29CA054216-05
Application #
2095752
Study Section
Diagnostic Radiology Study Section (RNM)
Project Start
1991-04-01
Project End
1997-03-31
Budget Start
1995-04-01
Budget End
1997-03-31
Support Year
5
Fiscal Year
1995
Total Cost
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
791277940
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Mody, Rajen J; Bui, Chuong; Hutchinson, Raymond J et al. (2010) FDG PET imaging of childhood sarcomas. Pediatr Blood Cancer 54:222-7
Shulkin, B L; Shapiro, B (1998) Current concepts on the diagnostic use of MIBG in children. J Nucl Med 39:679-88
Shulkin, B L; Chang, E; Strouse, P J et al. (1997) PET FDG studies of Wilms tumors. J Pediatr Hematol Oncol 19:334-8
Shulkin, B L; Wieland, D M; Baro, M E et al. (1996) PET hydroxyephedrine imaging of neuroblastoma. J Nucl Med 37:16-21
Shulkin, B L; Hutchinson, R J; Castle, V P et al. (1996) Neuroblastoma: positron emission tomography with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose compared with metaiodobenzylguanidine scintigraphy. Radiology 199:743-50
Macfarlane, D J; Shulkin, B L; Murphy, K et al. (1995) FDG PET imaging of paragangliomas of the neck: comparison with MIBG SPET. Eur J Nucl Med 22:1347-50
Shulkin, B L; Mitchell, D S; Ungar, D R et al. (1995) Neoplasms in a pediatric population: 2-[F-18]-fluoro-2-deoxy-D-glucose PET studies. Radiology 194:495-500
Shulkin, B L; Koeppe, R A; Francis, I R et al. (1993) Pheochromocytomas that do not accumulate metaiodobenzylguanidine: localization with PET and administration of FDG. Radiology 186:711-5
Shulkin, B L; Wieland, D M; Schwaiger, M et al. (1992) PET scanning with hydroxyephedrine: an approach to the localization of pheochromocytoma. J Nucl Med 33:1125-31